Newzen-138

Newzenpharma has developed compositions and methods for treating prostate cancer by targeting DNA repair within cancer/tumor cells. The technology inhibits BER capacity in cancer cells without compromising normal cell growth, slowing down tumor growth and metastasis. Compared to currently available chemotherapy treatment options for castrate-resistant prostate cancer, these methods provide effective treatment with fewer side effects but Newzen-138 has no side effects.